SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ·Healthcare·Biotechnology
$8.00
-4.81%
Mkt Cap $1.79B
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$35.00
Range $35.00 – $35.00
Implied Upside
+337.5%
Consensus $35.00 vs current $8.00
NASDAQ·Healthcare·Biotechnology
$8.00
-4.81%
Mkt Cap $1.79B
No recent rating data.
Price Target (4 analysts)
$35.00
Range $35.00 – $35.00
+337.5%
Consensus $35.00 vs current $8.00